Results 71 to 80 of about 7,965 (226)

Smart Polymer‐Based Drug Delivery Systems for Managing Infective Conjunctivitis: Advances and Future Prospects

open access: yesNano Select, Volume 7, Issue 6, June 2026.
The introduction covers the background and significance of conjunctivitis. It continues with a review of etiology, epidemiology, and clinical manifestations. Diagnostic methods are described, followed by discussions on pathophysiology and classification. Current treatment strategies, preventive measures, and therapeutic challenges are analyzed.
Xia Linkang   +11 more
wiley   +1 more source

Chemical structures of polyamines and PAMAM-G4 dendrimer.

open access: yes, 2013
Chemical structures of polyamines and PAMAM-G4 dendrimer.
Heidar-Ali Tajmir-Riahi (178288)   +3 more
core   +1 more source

PAMAM dendrimers based co-delivery of methotrexate and berberine for targeting of Hela cancer cells

open access: yesToxicology Reports
Polyamidoamine dendrimer (PAMAM) is a class of synthetic macromolecular polymers for targeted drug delivery. PAMAM dendrimers are characterized by a pure defined structure, adjustable nanoscale dimensions, mono-dispersity, and versatile surface ...
Hossein Majidzadeh   +8 more
doaj   +1 more source

Effect of methotrexate conjugated PAMAM dendrimers on the viability of MES-SA uterine cancer cells

open access: yesJournal of Pharmacy and Bioallied Sciences, 2014
The aim of this work was to synthesize methotrexate (MTX)-polyamidoamine (PAMAM) dendritic nanoconjugates and to study their effect on cell viability in uterine sarcoma cells.
Samreen Khatri   +2 more
doaj   +1 more source

Gold Nanoparticle–Trastuzumab Conjugates for HER2‐Positive Breast Cancer Treatment: Developments in Radionuclide Therapy, Multimodal Imaging, and Combination Strategies

open access: yesNano Select, Volume 7, Issue 6, June 2026.
ABSTRACT This work comprehensively examines recent advances in the treatment of human epidermal growth factor receptor 2 (HER2)‐positive breast cancer using trastuzumab‐conjugated gold nanoparticles (AuNPs). By analyzing several pivotal studies, it explores how these nanoplatforms enhance therapeutic specificity and efficacy while minimizing systemic ...
Tara Tarzi   +5 more
wiley   +1 more source

Potential Use of Folate-polyethylene glycol (PEG)-Appended Dendrimer (G3) Conjugate with alpha-Cyclodextrin as DNA Carriers to Tumor Cells

open access: yes, 2011
We previously reported that polyamidoamine STARBURST dendrimer (generation 3, G3) (dendrimer) conjugate with alpha-cyclodextrin (alpha-CyD) having an average degree of substitution of 2.4 of alpha-CyD (alpha-CDE) provided remarkable aspects as novel ...
Masayo Arizono   +9 more
core  

PAMAM dendrimer with 4-carbomethoxypyrrolidone - In vitro assessment of neurotoxicity

open access: yes, 2015
Cytotoxicity of cationic amino-terminated PAMAM dendrimer and modified PAMAM-pyrrolidone dendrimer was compared. LDH assay and cell visualization technique were employed. Mouse embryonic hippocampal cells (mHippoE-18) were used.
Klajnert-Maculewicz, Barbara   +5 more
core   +1 more source

Fluorinated Amphiphilic Dendrimer to Improve PET Imaging of Cancer

open access: yesSmall, Volume 22, Issue 35, 23 June 2026.
Fluorination of a self‐assembling dendrimer nanosystem reduced liver retention, accelerated renal clearance and improved biodistribution, ultimately enhancing tumor uptake and enabling more sensitive tumor detection by positron emission tomography (PET).
Béatrice Louis   +16 more
wiley   +1 more source

Dendrimers bind antioxidant polyphenols and cisplatin drug.

open access: yesPLoS ONE, 2012
Synthetic polymers of a specific shape and size play major role in drug delivery systems. Dendrimers are unique synthetic macromolecules of nanometer dimensions with a highly branched structure and globular shape with potential applications in gene and ...
Amine Abderrezak   +4 more
doaj   +1 more source

Ligand‐specific tuning of CLEC10A signalling strength and dendritic cell responses through engagement of different GalNAc‐containing glycan structures

open access: yesThe FEBS Journal, Volume 293, Issue 11, Page 3187-3210, June 2026.
The authors investigated the effects of various glycan ligands for CLEC10A, a lectin receptor expressed on dendritic cells (DCs). Monocyte‐derived DCs were stimulated with glycan‐conjugated dendrimers in combination with the TLR1/2 ligand Pam3CysK4, and responses were investigated at the mRNA and protein level.
Nadia L. van der Meijs   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy